1-2 of 2
Barry A. Siegel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Single-agent ibrutinib in relapsed or refractory follicular lymphoma: a phase 2 consortium trial

Clinical Trials & Observations
Nancy L. Bartlett, Brian A. Costello, Betsy R. LaPlant, Stephen M. Ansell, John G. Kuruvilla, Craig B. Reeder, Lim S. Thye, Daniel M. Anderson, Kilannin Krysiak, Cody Ramirez, Jing Qi, Barry A. Siegel, Malachi Griffith, Obi L. Griffith, Felicia Gomez, Todd A. Fehniger
Journal: Blood
Blood (2018) 131 (2): 182–190.
https://doi.org/10.1182/blood-2017-09-804641
Published: 2018
Includes: Supplemental data
Journal Articles

Ibrutinib Monotherapy in Relapsed/Refractory Follicular Lymphoma (FL): Preliminary Results of a Phase 2 Consortium (P2C) Trial

Nancy L. Bartlett, MD, Betsy R. LaPlant, MS, Jing Qi, MD PhD, Stephen M. Ansell, MD PhD, John G. Kuruvilla, MD, Craig B. Reeder, MD, Lim S. Thye, MD, Daniel M. Anderson, MD MPH, Charles Erlichman, MD, Barry A. Siegel, MD
Journal: Blood
Blood (2014) 124 (21): 800.
https://doi.org/10.1182/blood.V124.21.800.800
Published: 2014